Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Bay-593 | 2413020-56-9 | 99.9% | 476.53 g/mol | C26H31F3N2O3 | 10 MG
SDP

Catalog No. 5000288606
Encompass_Preferred

BAY-593 is an orally active geranylgeranyltransferase-I (GGTase-I) inhibitor that blocks YAP1/TAZ signaling and demonstrates antitumor activity in animal models. It is used as a research probe to study Rho-GTPase prenylation, YAP1/TAZ-dependent pathways, and related cancer biology applications.

  • Orally active GGTase-I inhibitor suitable for in vivo studies.
  • Blocks YAP1/TAZ signaling in cells and animals.
  • Demonstrates antitumor activity in animal models.
  • High purity solid form for research applications.
  • Available in small research pack sizes and as a DMSO solution for screening.

Catalog No. 50-002-88606 Supplier Medchemexpress LLC Supplier No. HY16157310MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

BAY-593 is an orally active geranylgeranyltransferase-I (GGTase-I) inhibitor that blocks YAP1/TAZ signaling and demonstrates antitumor activity in animal models. It is used as a research probe to study Rho-GTPase prenylation, YAP1/TAZ-dependent pathways, and related cancer biology applications.

  • Orally active GGTase-I inhibitor suitable for in vivo studies.
  • Blocks YAP1/TAZ signaling in cells and animals.
  • Demonstrates antitumor activity in animal models.
  • High purity solid form for research applications.
  • Available in small research pack sizes and as a DMSO solution for screening.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.